These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 7788650
1. [Simvastatin in the treatment of familial hypercholesterolemia]. Ceska R, Sobra J, Procházková R, Kvasilová M. Cas Lek Cesk; 1995 May 17; 134(10):310-3. PubMed ID: 7788650 [Abstract] [Full Text] [Related]
2. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia]. Ceska R, Sobra J, Kvasnicka J, Procházková R, Kvasilová M, Haas T. Cas Lek Cesk; 1996 Jul 26; 135(13):413-6. PubMed ID: 8925538 [Abstract] [Full Text] [Related]
4. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR. Arch Intern Med; 1990 Feb 26; 150(2):341-5. PubMed ID: 2405804 [Abstract] [Full Text] [Related]
5. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide]. Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L. Cardiologia; 1990 Apr 26; 35(4):335-40. PubMed ID: 2245435 [Abstract] [Full Text] [Related]
7. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial. Leclercq V, Harvengt C. Int J Clin Pharmacol Ther Toxicol; 1989 Feb 26; 27(2):76-81. PubMed ID: 2921098 [Abstract] [Full Text] [Related]
8. [Simvastatin in the treatment of hypercholesterolemia]. Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL. Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606 [Abstract] [Full Text] [Related]
9. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia]. Darioli R, Bovet P, Brunner HR, Bercher L. Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221 [Abstract] [Full Text] [Related]
10. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia]. Riesen WF, Keller U, Del Bufalo A, Reutter FW, Baur HR, Golay A, Bertel O, Kummer H, Kistler H, Ammann F. Schweiz Med Wochenschr; 1989 Dec 02; 119(48):1719-23. PubMed ID: 2694363 [Abstract] [Full Text] [Related]
11. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia. Lewis-Barned NJ, Ball MJ. N Z Med J; 1992 Jul 22; 105(938):284-6. PubMed ID: 1495661 [Abstract] [Full Text] [Related]
12. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G. Can J Cardiol; 1993 Jun 22; 9(5):405-12. PubMed ID: 8348392 [Abstract] [Full Text] [Related]
13. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin]. Brocard JJ, Keller U, Oberhänsli A, Riesen WF. Schweiz Med Wochenschr; 1991 Jun 29; 121(26):977-83. PubMed ID: 1862314 [Abstract] [Full Text] [Related]
14. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR. Wien Med Wochenschr; 1995 Jun 29; 145(21):577-83. PubMed ID: 8560901 [Abstract] [Full Text] [Related]
15. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor. Benítez S, Ordóñez-Llanos J, Franco M, Marín C, Paz E, López-Miranda J, Otal C, Pérez-Jiménez F, Sánchez-Quesada JL. Am J Cardiol; 2004 Feb 15; 93(4):414-20. PubMed ID: 14969613 [Abstract] [Full Text] [Related]
16. The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia. de Graaf J, Demacker PN, Stalenhoef AF. Neth J Med; 1993 Dec 15; 43(5-6):254-61. PubMed ID: 8107933 [Abstract] [Full Text] [Related]
17. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K, Sasaki J, Arakawa K. Clin Ther; 1989 Dec 15; 11(2):247-57. PubMed ID: 2736571 [Abstract] [Full Text] [Related]
18. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J. Pediatrics; 1996 May 15; 97(5):619-28. PubMed ID: 8628597 [Abstract] [Full Text] [Related]
19. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia. Geiss HC, Schwandt P, Parhofer KG. Exp Clin Endocrinol Diabetes; 2002 Jun 15; 110(4):182-7. PubMed ID: 12058342 [Abstract] [Full Text] [Related]
20. [Effects of simvastatin on blood levels of lipoprotein (a)]. Galetta F, Sampietro T, Basta G, Giannasi G, Bionda A. Minerva Med; 1995 Jun 15; 86(7-8):299-303. PubMed ID: 7478073 [Abstract] [Full Text] [Related] Page: [Next] [New Search]